1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
2. Department of Hematology/Oncology, Columbia University, New York, NY, USA;
3. Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA;
4. National Cancer Institute, Bethesda, MD, USA;
5. Department of Dermatology, Stanford University, Stanford, CA, USA;
6. Boston Medical Center, Boston, MA, USA;
7. Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland;
8. State Educational Institution of Military Medicine, St. Petersburg, Russia;
9. Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Clinic Essen, Germany;
10. Alba BioPharm Advisors, Inc, Raleigh, NC, USA;
11. Brightech International LLC, Somerset, NJ, USA;
12. Kings College London, London, England